
- Company
- Acumen
- Role
- Founder & CEO
- Est. Net Worth
- $3 Million (Est.)
- Stage
- Emerging
- Industry
- Finance
Jacqueline Novogratz
Founder & CEO at Acumen
About
Jacqueline Novogratz founded Acumen in 2001, pioneering the concept of 'patient capital' — long-term, risk-tolerant investment in social enterprises serving the world's poorest communities. Acumen has invested over $150 million in companies providing affordable healthcare, clean energy, education, and agriculture across Africa, South Asia, and Latin America. Novogratz's model challenged both traditional charity and conventional venture capital by proving that market-based approaches could deliver both social impact and financial sustainability.
Current Company
Acumen — Founder & CEO
Inventing Patient Capital
Jacqueline Novogratz spent a decade in traditional development finance — first at Chase Manhattan Bank, then at the Rockefeller Foundation — before concluding that neither pure charity nor conventional venture capital could solve poverty at scale. In 2001, she founded Acumen with the concept of 'patient capital': long-term, below-market-rate investments in companies serving people living on less than $4 a day.
Acumen's model was radical. It invested equity in for-profit companies providing essential goods — clean water, solar energy, affordable healthcare, agricultural inputs — to the world's poorest communities, then measured success not just in financial returns but in the number of lives improved. The fund's early investments in companies like d.light (solar lanterns) and WaterHealth International proved that market-based solutions could reach the 'bottom of the pyramid' at scale.
Moral Imagination at Scale
Novogratz's influence extends beyond Acumen's portfolio. She trained a generation of social entrepreneurs through the Acumen Fellows program, which has placed leaders in over 90 countries. Her books, 'The Blue Sweater' and 'Manifesto for a Moral Revolution,' argue that solving global poverty requires a new kind of leadership — one that combines the accountability of markets with the compassion of aid work.
After two decades, Acumen has invested over $150 million in 170+ companies across Africa, South Asia, Latin America, and the United States, improving the lives of over 400 million people. Novogratz's patient capital model has been adopted by dozens of impact investing funds worldwide, fundamentally expanding what the finance industry considers a viable investment thesis.